Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study

Abstract

This study highlighted the role of HVEM on T cells as a novel molecular-modified factor for MG risk and validated the causality between T cells and MG. These findings may advance our understanding of MG's immunopathology and facilitate the future development of predictive disease-relevant biomarkers.